Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01263262 · ClinicalTrials.gov registry record
A Comparison of Infection Rates Between Two Surgical Sites
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 600
- Enrollment target
NCT01263262: Completed study, sponsored by Mayo Clinic.
NCT01263262 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 600 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01263262 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
Study Summary
Does the use of chlorhexidine scrub prior to cutaneous surgery on the face increase the chances of toxicity to the eyes or ears? In addition, does the us eof chlorhexidine scrub on the face prior to cutaneous surgery decrease the chances of a post-operative wound infection?
Primary Outcome
Comparing ocular and ear toxicities between two institutions with differences in aseptic technique.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-08 |
What the finished NCT01263262 record still lists
NCT01263262 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01263262 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01263262 about?
NCT01263262 is a clinical study titled "A Comparison of Infection Rates Between Two Surgical Sites". Does the use of chlorhexidine scrub prior to cutaneous surgery on the face increase the chances of toxicity to the eyes or ears? In addition, does the us eof chlorhexidine scrub on the face prior to cutaneous surgery decrease the chances of a post-operative wound infection?
What is the current status of trial NCT01263262?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2011-01. Estimated completion is 2013-08.
Who is sponsoring clinical trial NCT01263262?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia